Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-11 Sale | 2024-11-13 5:35 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 30,000 | $55.62 | $1,668,678 | 282,162 (Indirect Direct) | View |
| 2024-10-14 Sale | 2024-10-15 6:00 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 4,293 | $46.28 | $198,680 | 328,829 (Indirect Direct) | View |
| 2024-04-15 Sale | 2024-04-17 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,582 | $59.91 | $1,173,232 | 408,122 (Indirect Direct) | View |
| 2024-03-15 Sale | 2024-03-18 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $72.48 | $1,449,628 | 427,704 (Indirect Direct) | View |
| 2024-03-11 Sale | 2024-03-12 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 14,385 | $77.04 | $1,108,263 | 474,872 (Indirect Direct) | View |
| 2024-02-20 Sale | 2024-02-21 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 6,370 | $79.67 | $507,498 | 420,757 (Indirect Direct) | View |
| 2024-02-15 Sale | 2024-02-16 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $80.36 | $1,607,177 | 426,959 (Indirect Direct) | View |
| 2024-01-29 Sale | 2024-01-31 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 50,000 | $60.51 | $3,025,573 | 487,377 (Indirect Direct) | View |
| 2024-01-16 Sale | 2024-01-18 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $62.5 | $1,250,058 | 446,959 (Indirect Direct) | View |
| 2023-05-30 Sale | 2023-06-01 5:44 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $64.88 | $1,621,894 | 466,959 (Direct) | View |
| 2023-04-25 Sale | 2023-04-27 5:37 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $50.67 | $1,266,638 | 491,959 (Direct) | View |
| 2023-03-29 Sale | 2023-03-31 5:49 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $44.46 | $1,111,504 | 516,959 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 6:11 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $48.25 | $1,206,243 | 530,570 (Direct) | View |
| 2023-01-27 Sale | 2023-01-31 5:34 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $51.47 | $1,286,798 | 548,693 (Direct) | View |
| 2022-12-28 Sale | 2022-12-30 5:33 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $40.93 | $1,023,290 | 573,693 (Direct) | View |
| 2022-11-28 Sale | 2022-11-30 5:36 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $54.03 | $1,350,827 | 519,861 (Direct) | View |
| 2022-10-26 Sale | 2022-10-28 5:43 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $54.81 | $1,370,191 | 558,612 (Direct) | View |
| 2022-09-28 Sale | 2022-09-30 5:42 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $64.61 | $1,615,160 | 323,612 (Direct) | View |
| 2022-08-29 Sale | 2022-08-31 5:45 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $66.84 | $1,671,084 | 348,612 (Direct) | View |
| 2022-07-27 Sale | 2022-07-29 5:38 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $75.91 | $1,897,747 | 373,612 (Direct) | View |
| 2022-06-29 Sale | 2022-07-01 6:00 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $61.59 | $1,539,862 | 298,612 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-16 Option Award | 2024-10-18 5:35 pm | N/A 2034-10-16 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 455,000 | $0 | 455,000 (Direct) | View |
| 2024-10-13 Exercise | 2024-10-15 6:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 8,333 | $0 | 328,829 (Direct) | View |
Ownership | 2024-09-06 5:06 pm | N/A 2034-03-22 | Oruka Therapeutics Inc. | ORKA | Kulkarni Samarth Director | 0 | $0 | 199,992 (Direct) | View |
| 2024-08-08 Gift | 2024-08-12 6:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 100,000 | $0 | 308,122 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-27 4:32 pm | N/A 2034-06-25 | Centessa Pharmaceuticals plc | CNTA | Kulkarni Samarth Director | 48,000 | $0 | 48,000 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-20 4:35 pm | N/A 2034-06-16 | Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director | 27,200 | $0 | 27,200 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-06 5:55 pm | N/A 2034-06-05 | Black Diamond Therapeutics Inc. | BDTX | Kulkarni Samarth Director | 30,550 | $0 | 30,550 (Direct) | View |
| 2024-04-15 Exercise | 2024-04-17 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,582 | $19.12 | 408,122 (Direct) | View |
| 2024-04-15 Exercise | 2024-04-17 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,582 | $0 | 408,122 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 5:45 pm | N/A 2034-03-20 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 183,750 | $0 | 183,750 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-18 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $19.12 | 427,704 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-18 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $0 | 427,704 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-12 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 28,250 | $0 | 474,872 (Direct) | View |
| 2024-02-18 Exercise | 2024-02-21 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 13,250 | $0 | 420,757 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $19.12 | 426,959 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $0 | 426,959 (Direct) | View |
| 2024-01-29 Exercise | 2024-01-31 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 50,000 | $19.12 | 487,377 (Direct) | View |
| 2024-01-29 Exercise | 2024-01-31 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 50,000 | $0 | 487,377 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $19.12 | 446,959 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 5:45 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,000 | $0 | 446,959 (Direct) | View |
| 2023-10-13 Option Award | 2023-10-17 5:51 pm | N/A 2033-10-13 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 77,500 | $0 | 77,500 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-23 5:07 pm | N/A 2033-06-22 | Centessa Pharmaceuticals plc | CNTA | Kulkarni Samarth Director | 48,000 | $0 | 48,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:25 pm | N/A 2033-06-07 | Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director | 27,200 | $0 | 27,200 (Direct) | View |
| 2023-05-30 Exercise | 2023-06-01 5:44 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $19.12 | 466,959 (Direct) | View |
| 2023-05-30 Exercise | 2023-06-01 5:44 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 466,959 (Direct) | View |
| 2023-05-16 Option Award | 2023-05-17 9:08 pm | N/A 2033-05-15 | Black Diamond Therapeutics Inc. | BDTX | Kulkarni Samarth Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2023-04-25 Exercise | 2023-04-27 5:37 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $19.12 | 491,959 (Direct) | View |
| 2023-04-25 Exercise | 2023-04-27 5:37 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 491,959 (Direct) | View |
| 2023-03-29 Exercise | 2023-03-31 5:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $19.12 | 516,959 (Direct) | View |
| 2023-03-29 Exercise | 2023-03-31 5:49 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 516,959 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-14 5:47 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 20,833 | $0 | 670,377 (Direct) | View |
| 2023-03-10 Option Award | 2023-03-14 5:47 pm | N/A 2033-03-10 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 265,000 | $0 | 670,377 (Direct) | View |
| 2023-03-13 Tax Withholding | 2023-03-14 5:47 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 9,444 | $43.22 | 670,377 (Direct) | View |
| 2023-02-27 Exercise | 2023-03-01 6:11 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $19.12 | 530,570 (Direct) | View |
| 2023-02-27 Exercise | 2023-03-01 6:11 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 530,570 (Direct) | View |
| 2023-02-18 Exercise | 2023-02-22 5:38 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 13,250 | $0 | 415,738 (Direct) | View |
| 2023-02-21 Tax Withholding | 2023-02-22 5:38 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 6,373 | $48.26 | 415,738 (Direct) | View |
| 2023-01-27 Exercise | 2023-01-31 5:34 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $19.12 | 548,693 (Direct) | View |
| 2023-01-27 Exercise | 2023-01-31 5:34 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 548,693 (Direct) | View |
| 2022-12-28 Exercise | 2022-12-30 5:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $19.12 | 573,693 (Direct) | View |
| 2022-12-28 Exercise | 2022-12-30 5:33 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 573,693 (Direct) | View |
| 2022-12-06 Exercise | 2022-12-08 5:35 pm | N/A 2025-09-10 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 58,233 | $0 | 369,111 (Direct) | View |
| 2022-12-06 Exercise | 2022-12-08 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 58,233 | $1.81 | 369,111 (Direct) | View |
| 2022-12-05 Tax Withholding | 2022-12-06 5:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,401 | $52.26 | 310,878 (Direct) | View |
| 2022-12-03 Exercise | 2022-12-06 5:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 40,000 | $0 | 310,878 (Direct) | View |
| 2022-11-28 Exercise | 2022-11-30 5:36 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $19.12 | 519,861 (Direct) | View |
| 2022-11-28 Exercise | 2022-11-30 5:36 pm | N/A 2027-12-01 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 519,861 (Direct) | View |
| 2022-10-26 Exercise | 2022-10-28 5:43 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 5,418 | $19.12 | 558,612 (Direct) | View |
| 2022-10-26 Exercise | 2022-10-28 5:43 pm | N/A 2027-05-03 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 558,612 (Direct) | View |
| 2022-10-26 Exercise | 2022-10-28 5:43 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,582 | $16.21 | 558,612 (Direct) | View |
| 2022-09-28 Exercise | 2022-09-30 5:42 pm | N/A 2027-05-03 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 323,612 (Direct) | View |
| 2022-09-28 Exercise | 2022-09-30 5:42 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $16.21 | 323,612 (Direct) | View |
| 2022-08-29 Exercise | 2022-08-31 5:45 pm | N/A 2027-05-03 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 348,612 (Direct) | View |
| 2022-08-29 Exercise | 2022-08-31 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $16.21 | 348,612 (Direct) | View |
| 2022-08-16 Option Award | 2022-08-18 5:37 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2022-07-27 Exercise | 2022-07-29 5:38 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 8,333 | $12.57 | 373,612 (Direct) | View |
| 2022-07-27 Exercise | 2022-07-29 5:38 pm | N/A 2026-07-15 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 373,612 (Direct) | View |
| 2022-07-27 Exercise | 2022-07-29 5:38 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 16,667 | $16.21 | 373,612 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 7:00 pm | N/A 2032-06-30 | Centessa Pharmaceuticals plc | CNTA | Kulkarni Samarth Director | 48,000 | $0 | 48,000 (Direct) | View |
| 2022-06-29 Exercise | 2022-07-01 6:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $12.57 | 298,612 (Direct) | View |
| 2022-06-29 Exercise | 2022-07-01 6:00 pm | N/A 2026-07-15 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 25,000 | $0 | 298,612 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 7:02 pm | N/A 2032-06-09 | Black Diamond Therapeutics Inc. | BDTX | Kulkarni Samarth Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-16 7:24 pm | N/A 2032-05-13 | Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director | 49,000 | $0 | 49,000 (Direct) | View |